Osteopetrotic (op/op) mice have a severe deficiency of osteoclasts, monocytes, and peritoneal macrophages because of a defect in the production of functional macrophage colony-stimulating factor (M-CSF) resulting from a mutation within the M-CSF gene. In this study, we examined whether daily 5-,ug injections of purified recombinant human M-CSF (rhM-CSF) for 14 d would cure these deficiencies in the mutant mice. Monocytes in the peripheral blood of the oplop mice were significantly increased in number after subcutaneous injections of the factor two or three times a day. In contrast, osteopetrosis in the long bones of op/op mice was completely cured by only one injection of rhM-CSF per day. Bone trabeculae in the diaphyses were removed . Many osteoclasts were detected on the surface of bone trabeculae in the metaphyses . Although development of tooth germs ofuninjected oplop mice was impaired, rhM-CSF injection restored the development ofmolar tooth germs and led to tooth eruption as a consequence ofthe recovery ofbone-resorbing activity. These results demonstrate that M-CSF is one ofthe factors responsible for the differentiation of osteoclasts and monocyte/macrophages under physiological conditions.
M
ice homozygous for the recessive osteopetrosis mutation (op/op) have a severe deficiency of osteoclasts, monocytes, and peritoneal macrophages (1) (2) (3) . These defects of the oplop mice can be neither transferred into irradiated normal mice (3) , nor cured by transplants of normal spleen or bone marrow cells (4) . Recently, oplop mice have been reported to have a defect in the production offunctional macrophage colony-stimulating factor (M-CSF) (5-7), and Yoshida et al. (5) found that the mutant mice have a 1-bp insertion within the coding region of the M-CSF gene on chromosome 3. Furthermore, Wiktor-jedrzejczak et al. (6) found that the macrophage deficiency in the peritoneal cavity of oplop mice is partially corrected by implantation of diffusion chambers containing M-CSF-producing L-929 cells. These findings strongly suggest that lack of functional M-CSF is the primary cause of the deficiency of monocyte/macrophages and osteoclasts in the op/op mice.
However, the role of M-CSF in osteoclast differentiation has been controversial . Although M-CSF has been reported to stimulate osteoclast formation in vitro (8, 9 ), other reports have been contradictory (10-13). Therefore, we examined whether the osteoclast deficiency in oplop mice could be cured by an exogenous supply of purified human recombinant M-CSF (rhM-CSF) . We found that this deficiency, as well as that ofmonocytes in the peripheral blood, was completely cured by daily injections of the rhM-CSF for 14 d.
Materials and Methods
Mice. FZ hybrid mice of + / + , opl + , and oplop genotypes were raised in our laboratory from breeding pairs of B6C3F1-a/a, opl + mice obtained from The Jackson Laboratory, Bar Harbor, ME. The mutant oplop mice could be clearly recognized by 10 d of age by failure of eruption of the incisors and by a domed skull.
Injection of Hemopoietic Factors into oplop Mice. Purified rhM-CSF was generously provided by Morinaga Milk Industry Co. Ltd. (Kanagawa, Japan) . 5 tog ofrhM-CSF was subcutaneously injected one to three times a day into oplop mice that were 11 d old at the start of the treatment . After consecutive injections of the factor for 14 d, the mice were killed at 25 d of age.
Hematological Measurements . Peripheral blood of the mice was obtained by retroorbital puncture under anesthesia. Nucleated cells were counted in a hemocytometer. Cellularity of the spleen was determined from counts ofsingle cell suspensions from the organ. Differential cell counts were performed on May-Griinwald/Giemsastained smears, and the results were confirmed by staining for nonspecific esterase.
Morphological Obsenaations. Tibias, femurs, and mandibles were fixed in a mixture of 2% paraformaldehyde and 2% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 2 h at 4°C. After having been rinsed in the buffer, some specimens were dehydrated in ethanol and embedded in JB-4 medium. 4-um-thick sections were stained with toluidine blue or for tartrate-resistant acid phosphatase (TRACP) activity (14). Other specimens were decalcified in 5% EDTA (pH 7.2), post-fixed in 1% osmic acid, and embedded in Epon 812. Ultrathin sections were stained and observed under the electron microscope. Whole calvariae were fixed in 10% phosphate-buffered formalin for 30 min at room temperature and stained for TRACP activity.
Results and Discussion
After consecutive injections of purified rhM-CSF into oplop mice, we compared their hematological profile with that of uninjected littermates (age matched) . As shown in Table 1 , we could not find monocytes in the peripheral blood of uninjected oplop mice by counting 200 nucleated cells. The number of monocytes in the peripheral blood of the mutant mice was increased by injections of rhM-CSF two or three times a day for 14 d, but not by a single daily injection, and the monocyte counts were significantly higher than those in phenotypically normal + /? mice (Table 1) . Monocyte counts in spleens were not significantly different in any of the mice (Table 2) . A significant number of erythroblasts was detected in the peripheral blood of uninjected op/op mutants, and the erythroblast number decreased after the rhM-CSF injections (Table 1) . This increase in erythroblast number in the uninjected mutants seems to reflect the extramedullary hemopoiesis that occurs in these animals, as well as the drop in this
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Cure of Osteoclast Deficiency in Osteopetrotic (op/op) Mice number after the rhM-CSF treatment and the recovery of bone marrow hemopoiesis (see below). These results demonstrate that injection ofpurified rhM-CSF is enough to cure the monocyte deficiency in oplop mice. By contrast, cure of osteopetrosis and development of red marrow in the long bones of oplop mice injected with rhM-CSF once a day for 14 d was readily noticeable by macroscopic observation. In the long bones ofuninjected oplop mice, development of the bone marrow cavity was prevented by an excessive amount of bone trabeculae, and osteoclasts were very rarely detected (Fig. 1 a) (1, 2, 4) . In the bones of rhM-CSF-injected oplop mice, however, the bone trabeculae in the diaphysis were mostly replaced by bone marrow showing active hemopoiesis. Furthermore, many osteoclasts were observed on the surface of bone trabeculae in the metaphyseal region (Fig. 1 b) . No obvious abnormality was found in these osteoclasts (Figs. 1, b and c) , except that the cells tended to be smaller in size and to contain a smaller number of nuclei than the osteoclasts found in normal mice; whereas the osteoclasts in op/op mice have been reported to have an abnormal cytoplasmic distribution ofacid phosphatase, toluidine bluepositive and electron-dense cytoplasmic inclusions, and hypertrophy of clear zones and ruffled borders (1, 2). TRACPpositive mononucleated cells were found in the bone marrow cavity of the rhM-CSF-injected oplop mice (Fig. 1 b) , consistent with the finding of WiktorJedrzejczak et al. (6) that TRACP-positive cells were detected in the bone marrow of oplop mice implanted with diffusion chambers containing L-929 cells. These observations demonstrate that a single injection of rhM-CSF once a day for 14 d is sufficient to cure the osteoclast deficiency in the long bones of op/op mice.
Failure of tooth eruption due to reduced bone resorption is a common feature of mammalian osteopetrotic mutants . As shown in Fig. 2 a, Table 2 .
Hematological Parameters of Spleen of Uninjected and M-CSF-injected op/op Mice and Uninfected Normal Littermates
Mice used in this experiment and in Table 1 were the same . Abbreviations used in this Table are the same as those used in Table 1 . 200 cells were counted in each sample .
completely ankylosed to bone trabeculae, and the periodontal ligament failed to develop. TRACP-positive cells were hardly detectable in the mandibles. In contrast, in the mandibles of the oplop mice injected with rhM-CSF once a day for 14 d, the mucous membrane covering the second and third molars was broken down in places, and the crown of these molars emerged through these perforations into the oral cavity ( On the inner surface o£ calvariae of oplop mice injected with rhM-CSF two or three times a day for 14 d, we found more osteoclasts than in age-matched + /? mice, and their distribution was similar to that in + /? mice (data not shown) . Our present study demonstrates that the deficiency in osteoclasts and monocytes in op/op mice is caused by the absence of functional M-CSF. Interestingly, osteoclasts in different bones and monocytes in peripheral blood showed different responsiveness to the rhM-CSF injections. Osteoclasts appearing in response to the rhM-CSF injections showed a distribution similar to that observed in normal mice and actively participated in physiological bone remodeling. These observations strongly suggest that M-CSF plays an essential role in the differentiation of osteoclasts and monocyte/macrophages under physiological conditions. Since our present experimental system does not allow us to further analyze the We thank Morinaga Milk Industry Co. Ltd. for the generous gift of purified rhM-CSF. We also thank Miss M. Sato for technical assistance .
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precise role of M-CSF in osteoclast and macrophage differentiation, and since some stromal cell lines derived from newborn mouse calvaria or adult mouse bone marrow can support osteoclast differentiation (15), we have recently established stromal cell lines from newborn oplop mouse calvariae. We found that some of the cell lines can support the differentiation of macrophages and osteoclasts only when M-CSF is exogenously supplied (manuscript in preparation), confirming our present results. Availability of the M-CSF-deficient mice and stromal cell lines derived from them will provide a unique opportunity to clarify the physiological role of M-CSF. 
